Ben-Tzvi Avraham bought INDP
January 20, 2026 · Form 4 insider transaction
Ben-Tzvi Avraham bought 25,000 shares of Indaptus Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderBen-Tzvi Avraham
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 20, 2026
Filing dateJanuary 22, 2026
Shares owned after25,100
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person acquired 25,000 shares of restricted common stock of the Issuer pursuant to a consulting agreement dated January 20, 2026, which shares vested 100% upon grant.; Includes 100 shares of common stock of the Issuer held in a Roth IRA.